Updated:
ALPINE BIOVENTURES, GP, LLC
ALPINE BIOVENTURES, GP, LLC is a venture capital GP focused on early-stage biotechnology investments, with no publicly disclosed portfolio or team.
ALPINE BIOVENTURES, GP, LLC
ALPINE BIOVENTURES, GP, LLC is a limited liability company formed as a general partner for a venture capital fund targeting the biotechnology sector. The firm's name connects to the bioventures ecosystem, but no founding year, founding principals, or wealth origin are publicly documented. The firm's investment strategy centers on biotechnology venture capital, focusing on early-stage therapeutic companies. Typical biotech VC strategies involve investing in platform technologies (e.g., gene therapy, antibody engineering, small-molecule discovery) and taking board seats. Without a disclosed portfolio, it is not possible to cite specific investments. Geographic focus is unclear but likely US-centered, given the prevalence of biotech hubs in Boston, San Francisco, and San Diego. No team size, additional offices, or philanthropic structures are known. The firm does not have a public LinkedIn presence or a publicly searchable website, limiting available operational details. No recent activity can be verified. The structural differentiator for ALPINE BIOVENTURES, GP, LLC is its existence as a formal GP entity, indicating it operates a committed fund structure with defined limited partners. This contrasts with firms that manage single-family office direct investments or evergreen vehicles. The fund likely has a predefined investment period and lifecycle, which shapes its deployment pace and exit timeline.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
—
Country
—
City
—
Corporate office
—
Sector focus
Frequently asked questions
What is the investment strategy of ALPINE BIOVENTURES, GP, LLC?
The firm operates as a venture capital general partner focused on biotechnology. Its strategy likely targets early-stage therapeutic platforms, such as gene therapy, cell therapy, or antibody engineering, though specific details are not publicly available (public record).
Is ALPINE BIOVENTURES, GP, LLC a single-family office or a traditional venture firm?
The 'GP, LLC' designation indicates it is structured as a general partner for a venture capital fund, making it a traditional venture firm with limited partners. This differs from a single-family office, which manages capital for one family (public record).
Does ALPINE BIOVENTURES, GP, LLC have a publicly available website?
No publicly accessible website or LinkedIn profile has been found for the firm as of mid-2026. This limits the ability to confirm its team, portfolio, or investment history (public record).
Who are the principals or investment team at ALPINE BIOVENTURES, GP, LLC?
No named principals or investment professionals are publicly listed for this firm. The team composition remains undisclosed (public record).
What is the fund size or AUM of ALPINE BIOVENTURES, GP, LLC?
The firm's assets under management are not publicly disclosed. As a GP entity, it may have raised a fund of unknown size (public record).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: